Skip to main content
. 2017 Mar 17;8(30):49110–49122. doi: 10.18632/oncotarget.16308

Figure 7. NRP2 expression is negatively related to the expression of miR-196a-3p in breast cancers.

Figure 7

(A) NRP2 immunostaining of primary tumors and corresponding non-tumor tissues(Left, ×100; Right, ×200). (B) NRP2 expression in 12 different kinds of breast cancers was measured by qRT-PCR. (3 luminal A, 3 luminal B, 3 ERBB2 overexpressing, and 3 basal-like cases). The results are means of three independent experiments ± S.D. (*p<0.05,**p< 0.01).